Vigorous allograft rejection in the absence of danger

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 3065-3071

  Bingaman, Adam W ^a   Ha, Jongwon ^a   Waitze, Seung Yeun ^a   Durham, Megan M ^a   Cho, Hong Rae ^b   Tucker Burden, Carol ^a   Hendrix, Rose ^a   Cowan, Shannon R ^a   Pearson, Thomas C ^a,c   Larsen, Christian P ^a,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Ulsan   (South Korea)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BONE GRAFT; GRAFT REJECTION; HEART GRAFT; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034654349     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.3065     Document Type: Article

References (50)

1. Bretscher, P., and M. Cohn. 1970. A theory of self-nonself discrimination: paralysis and induction involve the recognition of one and two determinants on an antigen, respectively. Science 169:1042.
2. Janeway, C. A., Jr. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13:11.
3. von Boehmer, H., and P. Kisielow. 1990. Self-nonself discrimination by T cells. Science 248:1369.
4. Kappler, J. W., N. Roehm, and P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273.
5. van Meerwijk, J. P., S. Marguerat, R. K. Lees, R. N. Germain, B. J. Fowlkes, and H. R. MacDonald. 1997. Quantitative impact of thymic clonal deletion on the T cell repertoire. J. Exp. Med. 185:377.
6. lo thymocytes in vivo. Science 250: 1720.
7. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63:1249.
8. Jones, L. A., L. T. Chin, D. L. Longo, and A. M. Kruisbeck. 1990. Peripheral clonal elimination of functional T cells. Science 250:1726.
9. de St Groth, B. F. 1998. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol. Today 19:448.
10. Heath, W. R., C. Kurts, J. F. Miller, and F. R. Carbone. 1998. Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J. Exp. Med. 187: 1549.
11. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991.
12. Matzinger, P. 1998. An innate sense of danger. Semin. Immunol. 10:399.
13. Schonrich, G., U. Kalinke, F. Momburg, M. Malissen, G. J. Hammerling, and B. Arnold. 1991. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65:293.
14. Morahan, G., J. Allison, and J. F. A. P. Miller. 1989. Tolerance of class I histocompatibility antigens expressed extrathymically. Nature 339:622.
15. Burkly, L. C., D. Lo, K. Osami, R. L. Brinster, and R. A. Flavell. 1989. T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E. Nature 342:564.
16. Adams, T. E., S. Alpert, and D. Hanahan. 1987. Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic β cells. Nature 325:223.
17. Bohme, J., K. Haskins, P. Stecha, W. van Ewijk, M. LeMeur, P. Gerlinger, C. Benoist, and D. Mathis. 1989. Transgenic mice with 1-A on islet cells are normoglycemic but immunologically intolerant. Science 244:1179.
18. Morahan, G., F. E. Brennan, P. S. Bhathal, J. Allison, K. O. Cox, and J. F. Miller. 1989. Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc. Natl. Acad. Sci. USA 86:3782.
19. Ohashi, P. S., S. Oehen, K. Buerki, H. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. M. Zinkemagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305.
20. Oldstone, M. B., M. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319.
21. Murphy, K. M., C. T. Weaver, M. Elish, P. M. Allen, and D. Y. Loh. 1989. Peripheral tolerance to allogeneic class II histocompatibility antigens expressed in transgenic mice: evidence against a clonal-deletion mechanism. Proc. Natl. Acad. Sci. USA 86:10034.
22. k, and non-H-2 antigens in rejection. Transplantation 16:343.
23. Larsen, C. P., D. Z. Alexander, D. Hollenbaugh, E. T. Elwood, S. C. Ritchie, A. Aruffo, R. Hendrix, and T. C. Pearson. 1996. CD40-gp39 interactions play a critical role during allograft rejection. Transplantation 61:4.
24. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J. Exp. Med. 186:47.
25. Shahinian, A., K. Pfeffer, K. P. Lee, T. M. Kundig, K. Kishihara, A. Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
26. + T cells via signal 1 alone. J. Immunol. 161:5226.
27. + T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions. J. Immunol. 160:3180.
28. Ljunggren, H. G., and K. Karre. 1990. In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 11:237.
29. Bennett, M. 1987. Biology and genetics of hybrid resistance. Adv. Immunol. 41:333.
30. Inaba, K., and R. M. Steinman. 1984. Resting and sensitized T lymphocytes exhibit distinct stimulatory requirements for growth and lymphokine release. J. Exp. Med. 160:1711.
31. Lassila, O., O. Vainio, and P. Matzinger. 1988. Can B cells turn on virgin T cells? Nature 334:253.
32. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258:1156.
33. Kaye, J., and S. M. Hedrick. 1988. Analysis of specificity for antigen, Mls, and allogeneic MHC by transfer of T-cell receptor α- and β-chain genes. Nature 336:580.
34. Nahill, S. R., and R. M. Welsh. 1993. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J. Exp. Med. 177:317.
35. Burrows, S. R., R. Khanna, J. M. Burrows, and D. J. Moss. 1994. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J. Exp. Med. 179:1155.
36. + T cells. J. Exp. Med. 186:239.
37. + T cells specific for a pancreatic β cell neoantigen. Immunity 2:573.
38. Alferink, J., A. Tafuri, D. Vestweber, R. Hallmann, G. J. Hammerling, and B. Arnold. 1998. Control of neonatal tolerance to tissue antigens by peripheral T cell trafficking. Science 282:1338.
39. Hamano, K., M. A. Rawsthorne, A. R. Bushell, P. J. Morris, and K. J. Wood. 1996. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Transplantation 62:856.
40. Ford, W. L., and R. C. Atkins. 1973. The proportion of lymphocytes capable of recognizing strong transplantation antigens in vivo. Adv. Exp. Med. Biol. 29:255.
41. Lindahl, K. F., and D. B. Wilson. 1977. Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J. Exp. Med. 145:508.
42. Wilson, D. B., J. Blyth, and P. Nowell. 1968. Quantitative studies on the mixed lymphocyte interaction in rats. III. Kinetics of the response. J. Exp. Med. 128: 1157.
43. Sherman, L. A., and S. Chattopadhyay. 1993. The molecular basis of allorecognition. Annu. Rev. Immunol. 11:385.
44. Bevan, M. J. 1984. High determinant density may explain the phenomenon of alloreactivity. Immunol. Today 5:128.
45. Viola, A., and A. Lanzavecchia. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104.
46. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434.
47. Newstead, C. G., P. A. Johnston, E. J. Will, and A. M. Davison. 1998. The case for withdrawal of cyclosporin after renal transplantation. Nephrol. Dial. Transplant. 13:28.
48. Devlin, J., D. Doherty, L. Thomson, T. Wong, P. Donaldson, B. Portmann, and R. Williams. 1998. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology 27:926.
49. Mazariegos, G. V., J. Reyes, I. R. Marino, A. J. Demetris, B. Flynn, W. Irish, J. McMichael, J. J. Fung, and T. E. Starzl. 1997. Weaning of immunosuppression in liver transplant recipients. Transplantation 63:243.
50. Douek, D. C., R. D. McFarland, P. H. Keiser, E. A. Gage, J. M. Massey, B. F. Haynes, M. A. Polis, A. T. Haase, M. B. Feinberg, J. L. Sullivan, et al. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396:690.